- Home
- WTS vs BMRN Comparison
WTS vs BMRN Comparison
Compare WTS & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTS
- BMRN
- Stock Information
- Founded
- WTS 1874
- BMRN 1996
- Country
- WTS United States
- BMRN United States
- Employees
- WTS N/A
- BMRN N/A
- Industry
- WTS Metal Fabrications
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WTS Industrials
- BMRN Health Care
- Exchange
- WTS Nasdaq
- BMRN Nasdaq
- Market Cap
- WTS 9.3B
- BMRN 11.1B
- IPO Year
- WTS 1986
- BMRN 1999
- Fundamental
- Price
- WTS $279.98
- BMRN $54.71
- Analyst Decision
- WTS Buy
- BMRN Buy
- Analyst Count
- WTS 5
- BMRN 20
- Target Price
- WTS $253.80
- BMRN $92.21
- AVG Volume (30 Days)
- WTS 152.1K
- BMRN 2.1M
- Earning Date
- WTS 10-29-2025
- BMRN 10-28-2025
- Dividend Yield
- WTS 0.75%
- BMRN N/A
- EPS Growth
- WTS 12.86
- BMRN 154.69
- EPS
- WTS 9.30
- BMRN 3.40
- Revenue
- WTS $2,285,700,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- WTS $5.05
- BMRN $13.35
- Revenue Next Year
- WTS $4.35
- BMRN $9.18
- P/E Ratio
- WTS $30.02
- BMRN $16.10
- Revenue Growth
- WTS 2.96
- BMRN 18.36
- 52 Week Low
- WTS $177.59
- BMRN $52.48
- 52 Week High
- WTS $287.89
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- WTS 53.44
- BMRN 45.78
- Support Level
- WTS $276.65
- BMRN $53.19
- Resistance Level
- WTS $287.09
- BMRN $56.26
- Average True Range (ATR)
- WTS 4.30
- BMRN 1.17
- MACD
- WTS -0.50
- BMRN 0.23
- Stochastic Oscillator
- WTS 45.73
- BMRN 51.85
About WTS Watts Water Technologies Inc.
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.